[Streptogramins and glycopeptides].
Tsuji
Akiyoshi
A
Department of Infection Control and Prevention, School of Nursing, Faculty of Medicine, Toho University.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D004304:Dosage Forms; D016984:Enterococcus faecium / Q000187:drug effects; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D016106:Methicillin Resistance; D013211:Staphylococcus aureus / Q000187:drug effects; D025361:Streptogramins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D017334:Teicoplanin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D025361:Streptogramins; D017334:Teicoplanin; D014640:Vancomycin